← Back to Clinical Trials
Recruiting NCT04133675

BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence

Trial Parameters

Condition Stress Urinary Incontinence
Sponsor Corewell Health East
Study Type INTERVENTIONAL
Phase N/A
Enrollment 110
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2019-12-18
Completion 2027-10
Interventions
BTL EmsellaSham BTL Emsella

Brief Summary

Stress urinary incontinence (SUI) is a condition that affects both men and women. SUI is the involuntary leakage of urine caused by an increase in intra-abdominal pressure from activities such as exercise, coughing, laughing, or sneezing. It can significantly affect quality of life as patients avoid activities or behaviors that cause leakage. This clinical trial will compare the efficacy of the Emsella chair to sham and determine if electromagnetic technology is effective in the treatment of SUI.

Eligibility Criteria

Inclusion Criteria: 1. Able to read, understand, and provide written, dated, informed consent prior to screening, and be likely to comply with study protocol, including independently complete study questionnaires and communicate with study personnel about AEs and other clinically important information. 2. Females and males, 18 to 80 years of age, inclusive, at screening 3. Positive Cough or Bladder Stress Test at screening 4. Subject agrees not to start any new treatment (medication or otherwise) during the treatment and follow-up periods. 6\. Subject agrees to maintain a stable dose of any medication known to affect lower urinary tract function, including but not limited to anticholinergics, tricyclic antidepressants, beta-3 adrenergic agonist, or α-adrenergic blockers, throughout the treatment and follow-up periods. For Females Only: * Subject agrees to discontinue use of bladder support devices, including but not limited to vaginal pessary, during the screening, treatment, and follo

Related Trials